Cargando…
Safety and Adherence to Venom Immunotherapy During COVID-19 Pandemic
BACKGROUND: According to expert consensus, the time interval between Hymenoptera venom immunotherapy (VIT) injections can be extended up to 12 weeks, without significant impact on efficacy and safety. However, the coronavirus disease 2019 pandemic caused longer delays, and no recommendations are ava...
Autores principales: | Bilò, M. Beatrice, Braschi, M. Chiara, Piga, Mario A., Antonicelli, Leonardo, Martini, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690271/ https://www.ncbi.nlm.nih.gov/pubmed/33249121 http://dx.doi.org/10.1016/j.jaip.2020.11.030 |
Ejemplares similares
-
Honeybee Venom Immunotherapy: A Comparative Study Using Purified and Nonpurified Aqueous Extracts in Patients with Normal Basal Serum Tryptase Concentrations
por: Bilò, M. Beatrice, et al.
Publicado: (2012) -
Venom immunotherapy: safety and tolerability of the build‐up phase with depot versus aqueous preparations
por: Pravettoni, Valerio, et al.
Publicado: (2022) -
Hymenoptera Venom Immunotherapy in Dogs: Safety and Clinical Efficacy
por: Rostaher, Ana, et al.
Publicado: (2023) -
Platelet‐activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy?
por: Bilò, Maria Beatrice, et al.
Publicado: (2021) -
Venom immunotherapy during COVID-19 pandemic: Experience from a University Allergy Center in Northern Italy
por: Dell’Edera, Alessandro, et al.
Publicado: (2020)